Nestle India and Dr. Reddy’s have officially inked a deal to establish a joint venture (JV), aiming to introduce cutting-edge nutraceutical brands to consumers in India and other designated regions.
This collaboration will unite the renowned global assortment of nutritional health solutions, including vitamins, minerals, herbals, and supplements from Nestle Health Science (NHSc), while also harnessing the commercial expertise of Dr. Reddy’s.
The joint venture partners will license specific brands to the JV company.
Continue Exploring: Nutraceutical industry growing beyond expectations: FSSAI chief
Optifast, Peptamen, Resource Diabetic, Osteo Bi-Flex, Ester-C, Nature’s Bounty, and Resource Renal and Resource Dialysis will be some of the brands that the Nestle Group will licence. In the OTC and nutrition markets, Dr. Reddy’s will licence brands such Becozinc, Kidrich-D3, Celevida, Rebalanz, and Antoxid. Headquartered in Hyderabad, the joint venture company is anticipated to start operations in the second quarter of FY25.
“This partnership will empower us to establish a strong retail and distribution network, bringing our brands within reach of consumers and fostering a significant impact on enhancing quality of life,” remarked Suresh Narayanan, Chairman and Managing Director of Nestlé India.
“This innovative strategy of capitalizing on the mutually reinforcing strengths of both parent companies will enhance accessibility and affordability for consumers,” commented M.V. Ramana, CEO of Branded Markets (India & Emerging Markets) at Dr. Reddy’s.
Continue Exploring: Govt panel explores shifting nutraceutical regulation from FSSAI to CDSCO
